Join the Sotorasib group to help and get support from people like you.
Sotorasib News
Sotorasib + Panitumumab Beneficial for Chemorefractory Metastatic CRC
TUESDAY, Oct. 24, 2023 – For patients with chemorefractory metastatic colorectal cancer, the KRAS G12C inhibitor sotorasib in combination with the epidermal growth factor receptor inhibitor...
FDA Approves Lumakras (sotorasib) for KRAS G12C-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
THOUSAND OAKS, Calif., May 28, 2021 /PRNewswire/ – Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Lumakras (sotorasib) for the treatment of adult...
Ask a question
To post your own question to this support group, sign in or create an account.